Status:
COMPLETED
Effect of a Non-Invasive Brain Stimulation Technique on Smoking Cessation Behaviors
Lead Sponsor:
University of Minnesota
Conditions:
Tobacco Use Disorder
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
In this pilot study, the feasibility of using tDCS (a non-invasive brain stimulation technique) while performing a task requiring cognitive flexibility will be examined in smokers and initial data wil...
Eligibility Criteria
Inclusion
- Be between the ages of 18 and 64
- Smoked (on average) at least 5 cigarettes per day
- Be motivated to quit smoking
Exclusion
- Unstable medical or psychiatric conditions
- Any medical conditions with neurological sequelae
- History of loss of consciousness of greater than 30 minutes duration or loss of consciousness with neurological sequelae
- Have any medical condition or use any medication that would either increase risk of subjects participating in this study (e.g., medications that lower the seizure threshold) or that would impact measures of interest (e.g. smoking cessation medications).
- Are pregnant or planning to become pregnant during the study
- Current use of pacemaker, intracranial electrodes or implanted defibrillator
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 21 2018
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT03386253
Start Date
January 1 2018
End Date
November 21 2018
Last Update
March 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical and Translational Sciences Institute
Minneapolis, Minnesota, United States, 55455